The T-cell counts were significantly reduced in COVID-19 patients—the surviving T cells in severe COVID-19 patients with CD4 T-cell counts were lower than 400 cells/μl (Moon, 2020; Zheng et al., 2020)—but which were still higher than those of patients with HIV/AIDS in this study (226 cells/μl). The gene discussed is CD4; the disease is AIDS.